Aspira Women's Health Inc. (AWHL) vs T2 Biosystems, Inc. (TTOO)

Aspira Women's Health Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $2.4M — 2.7× the size. Aspira Women's Health Inc. grew revenue faster over the last twelve months: −8.00% against −30.2%. Aspira Women's Health Inc. has the higher net margin (−117.1% vs −559.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Aspira Women's Health Inc. leads on 10 and T2 Biosystems, Inc. on 5.

Valuation

Metric AWHL TTOO Diagnostics & Research median
P/E n/m n/m 35.56
P/S 1.19 n/m 4.37
P/B n/m n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 1.36 6.26 5.51
Earnings yield (106.09%) 0.00% (1.89%)
Free cash flow yield (46.46%) 0.00% (0.15%)

Profitability

Metric AWHL TTOO Diagnostics & Research median
Gross margin 58.78% (76.76%) 50.89%
Operating margin (80.75%) (542.59%) (8.57%)
Net margin (117.07%) (559.52%) (6.37%)
Free cash flow margin (55.32%) (476.64%) 0.00%
Return on equity 201.29% 277.61% (2.92%)
Return on assets (213.58%) (140.00%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AWHL TTOO Diagnostics & Research median
Revenue growth (TTM) (8.00%) (30.19%) 7.69%
EPS growth (last fiscal year) 60.22% 98.44% 25.92%
Revenue growth, 5-year CAGR 14.66% (7.29%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL TTOO Diagnostics & Research median
Debt to equity (0.27) 0.00 0.11
Current ratio 0.52 0.40 2.02
Net debt to EBITDA 0.00 0.32 0.70

Dividend

Metric AWHL TTOO Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric AWHL TTOO Diagnostics & Research median
Market cap 2.44m 6.48m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack